<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">While not the intent of this review, we briefly comment on ethical issues related to vaccine development and policy. A significant ethical issue is how and under what conditions should pregnant women be included in Zika vaccine trials, given the unknown possible effects on the unborn developing child. Recent opinions on this question have been published.
 <xref rid="bib68" ref-type="bibr">
  <sup>68</sup>
 </xref> Other issues include how to provide vaccine to those in lower income countries who cannot afford it and, given historic new vaccine pricing, how a vaccine can be utilized in poorer countries where outbreaks may occur. If vaccine supplies are limited, who shall be prioritized?
</p>
